On Tuesday, Novartis AG ADR (NYSE: NVS) was -1.68% drop from the session before settling in for the closing price of $111.48. A 52-week range for NVS has been $92.35 – $120.92.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 1.74% over the past five years. When this article was written, the company’s average yearly earnings per share was at 7.00%. With a float of $1.90 billion, this company’s outstanding shares have now reached $1.98 billion.
Let’s look at the performance matrix of the company that is accounted for 75883 employees. In terms of profitability, gross margin is 74.73%, operating margin of 28.81%, and the pretax margin is 26.77%.
Novartis AG ADR (NVS) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Novartis AG ADR stocks. The insider ownership of Novartis AG ADR is 0.00%, while institutional ownership is 6.93%. The most recent insider transaction that took place on Aug 12 ’24, was worth 733,572.
Novartis AG ADR (NVS) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 7.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.07% during the next five years compared to 13.99% growth over the previous five years of trading.
Novartis AG ADR (NYSE: NVS) Trading Performance Indicators
You can see what Novartis AG ADR (NVS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.84. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.13. Likewise, its price to free cash flow for the trailing twelve months is 12.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 5.87, a number that is poised to hit 2.07 in the next quarter and is forecasted to reach 8.71 in one year’s time.
Technical Analysis of Novartis AG ADR (NVS)
Novartis AG ADR (NYSE: NVS) saw its 5-day average volume 2.16 million, a negative change from its year-to-date volume of 2.23 million. As of the previous 9 days, the stock’s Stochastic %D was 54.37%. Additionally, its Average True Range was 1.96.
During the past 100 days, Novartis AG ADR’s (NVS) raw stochastic average was set at 64.98%, which indicates a significant increase from 34.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 18.60% in the past 14 days, which was lower than the 19.93% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $108.27, while its 200-day Moving Average is $108.75. Nevertheless, the first resistance level for the watch stands at $111.61 in the near term. At $113.61, the stock is likely to face the second major resistance level. The third major resistance level sits at $114.72. If the price goes on to break the first support level at $108.50, it is likely to go to the next support level at $107.39. The third support level lies at $105.39 if the price breaches the second support level.
Novartis AG ADR (NYSE: NVS) Key Stats
There are 2,044,000K outstanding shares of the company, which has a market capitalization of 207.99 billion. As of now, sales total 51,722 M while income totals 11,941 M. Its latest quarter income was 13,558 M while its last quarter net income were 2,818 M.
